Webinar: Controlled Release for Nutraceuticals

We invite you to our next webinar:

“Controlled Release for Nutraceuticals”

During this webinar we will cover the key topics related to controlled release for nutraceuticals.

We will address:

New trends in enteric coating excipients by Marek Lachmann from BIOGRUND

Mechanistic study of cellulose ether to control the release of the API by David Nakhia from Shin-Etsu

Innovative technique for the granulation and coating processes, controlled release via Hot Melt fluidized bed by Dr. Lars Reinders from ROMACO

REGISTRATION

Join this webinar to learn from SE Tylose, BIOGRUND, Romaco Innojet and Pharma Excipients about controlled release for nutraceuticals.

Date & Time & Timezone: Sep 10, 2024 05:00 PM CET

Get more information & register here for free:

REGISTRATION

Speaker:

Marek Lachmann

Head of Research, BIOGRUND GmbH

Marek is a skilled pharmaceutical engineer and technician. He held several positions as a Senior Researcher, Innovation and Application Development Manager and Technical Manager in international pharmaceutical companies. The passionate researcher works at BIOGRUND GmbH as Head of Research where he is responsible for the development and optimisation of modern ready-to-use tableting and film coating premixes.

David Nakhla, Ph.D

Laboratory manager, Formulation scientist, SE Tylose USA, Inc.

David Nakhla is a pharmacist with a master’s degree in pharmaceutical analytical chemistry and a PhD degree in pharmaceutics from the University of Iowa. David currently holds the position of the lab manager and formulation scientist at SE Tylose USA pharmaceutical application laboratory in New Jersey.

dr. lars reinder

Dr. Lars Reinders

Head of Laboratory, Romaco Innojet GmbH

Dr. Lars Reinders has been working as a head of laboratory at Romaco Innojet GmbH since 2023. Together with his team, he processes pharmaceutical and nutraceutical raw materials using granulation, coating and hot melt processes in fluidized bed reactors. His field of work includes the establishment and optimization of existing formulations, their reformulation or the creation of new formulations. Before joining Romaco Innojet GmbH, Dr. Lars Reinders worked intensively on the topics of occupational safety in the aseptic production of personalized medicines and the analysis of pharmaceuticals. As part of his dissertation, he focused on cytostatics and monoclonal antibodies.

For more information & registration here:

REGISTRATION